Debt-to-equity of BioScience Health Innovations, Inc. from 31 May 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BioScience Health Innovations, Inc. quarterly Debt-to-equity in % history and change rate from 31 May 2020 to 30 Sep 2025.
  • BioScience Health Innovations, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 16%, a 50% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BioScience Health Innovations, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 16% -16% -50% 30 Sep 2025
Q2 2025 13% -69% -84% 30 Jun 2025
Q1 2025 9% 31 Mar 2025
Q4 2024 10% 31 Dec 2024
Q3 2024 31% 30 Sep 2024
Q2 2024 82% 30 Jun 2024
Q1 2023 -125% +160% +56% 31 Mar 2023
Q4 2022 -142% +70% +33% 31 Dec 2022
Q3 2022 -135% +113% +46% 31 Aug 2022
Q2 2022 -423% -1048% -168% 31 May 2022
Q1 2022 -285% +3002% +91% 28 Feb 2022
Q4 2021 -212% -1039% -126% 30 Nov 2021
Q3 2021 -248% +2597% +91% 31 Aug 2021
Q2 2021 625% +803% 31 May 2021
Q1 2021 -3287% 28 Feb 2021
Q4 2020 828% 30 Nov 2020
Q3 2020 -2845% 31 Aug 2020
Q2 2020 -178% 31 May 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.